AdventHealth Advanced Heart Failure CME 2025 (Videos + PDFs)

Comprehensive Update on Advanced Heart Failure, Heart Transplantation, LVADs, and Mechanical Circulatory Support

The AdventHealth Advanced Heart Failure CME 2025 program is a specialized educational course designed to provide healthcare professionals with the latest evidence-based advances in the diagnosis, treatment, and management of advanced heart failure. Developed for cardiologists, internists, advanced practice providers, and multidisciplinary heart failure teams, this program focuses on contemporary therapies, advanced heart failure interventions, transplantation strategies, and emerging technologies that are transforming cardiovascular care.

Through expert-led presentations and case-based discussions, participants will gain practical knowledge on referral timing for heart transplantation and durable mechanical circulatory support, management of cardiogenic shock, cardiogenomics, infiltrative cardiomyopathies, and structural heart interventions in heart failure patients. The course emphasizes early recognition, multidisciplinary collaboration, and timely referral to advanced heart failure centers to improve patient outcomes and survival.

Course Overview

Heart failure remains one of the leading causes of hospitalization, morbidity, and mortality worldwide. Advances in pharmacologic therapy, mechanical circulatory support, transplantation, genetics, and structural heart interventions have dramatically improved treatment options for patients with advanced heart failure. However, many patients continue to experience delayed referral for specialized therapies, limiting access to potentially life-saving interventions.

The AdventHealth Advanced Heart Failure CME 2025 program addresses these challenges by providing comprehensive education on modern heart failure management, advanced therapies, and evolving treatment paradigms. Participants will learn how to identify patients who may benefit from advanced interventions such as left ventricular assist devices (LVADs), heart transplantation, ECMO, and percutaneous valve therapies, while also reviewing contemporary approaches to cardiomyopathy management and cardiogenic shock.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Identify appropriate timing and indications for referral for heart transplantation and durable mechanical circulatory support.
• Evaluate treatment strategies for cardiogenic shock using echocardiography and invasive hemodynamic monitoring.
• Explain the role of cardiogenomics in patients with dilated cardiomyopathy.
• Analyze contemporary management of cardiogenic shock and acute myocardial infarction.
• Assess novel percutaneous mechanical circulatory support devices.
• Discuss current treatment options for cardiac amyloidosis and hypertrophic cardiomyopathy.
• Describe strategies to expand access to heart transplantation.
• Review the role of ECMO, donation after circulatory death (DCD), and hepatitis C-positive donor programs.
• Evaluate percutaneous valve interventions in patients with heart failure.

Major Topics Covered

❤️ Advanced Heart Failure Management

Comprehensive review of:

• Stages of heart failure
• Advanced heart failure recognition
• Referral criteria
• Prognostic assessment
• Long-term management strategies

Clinical Focus

• Improving survival
• Reducing hospitalizations
• Optimizing quality of life

💊 Guideline-Directed Medical Therapy (GDMT)

Latest updates on:

• ARNI therapy
• SGLT2 inhibitors
• Beta-blockers
• Mineralocorticoid receptor antagonists
• Advanced pharmacologic therapies

Treatment Goals

• Disease modification
• Symptom improvement
• Prevention of progression

🔧 Mechanical Circulatory Support (MCS)

Detailed coverage of:

• Left Ventricular Assist Devices (LVADs)
• Temporary mechanical support devices
• Bridge-to-transplant strategies
• Destination therapy

Topics Include

• Patient selection
• Timing of implantation
• Long-term outcomes
• Complication management

🫀 Heart Transplantation

Current approaches to:

• Transplant evaluation
• Candidate selection
• Timing of referral
• Post-transplant outcomes

Emerging Strategies

• Expanded donor criteria
• Organ allocation updates
• Transplant accessibility initiatives

⚡ Cardiogenic Shock

Advanced management of:

• Acute decompensated heart failure
• Myocardial infarction-related shock
• Hemodynamic instability

Key Areas

• Shock classification
• Hemodynamic monitoring
• Mechanical support utilization
• Critical care management

📡 Echocardiography & Hemodynamic Monitoring

Practical applications of:

• Echocardiographic assessment
• Invasive hemodynamic measurements
• Right heart catheterization
• Pulmonary artery pressure monitoring

Clinical Applications

• Diagnosis
• Risk stratification
• Therapy optimization

🧬 Cardiogenomics & Genetic Cardiomyopathies

Comprehensive review of:

• Dilated cardiomyopathy genetics
• Inherited cardiomyopathies
• Genetic testing strategies
• Family screening

Emerging Applications

• Precision medicine
• Personalized treatment planning

🦠 Cardiac Amyloidosis

Updated guidance on:

• Early diagnosis
• Imaging techniques
• Biomarker utilization
• Novel therapies

Clinical Importance

Early recognition significantly improves outcomes.

🫀 Hypertrophic Cardiomyopathy (HCM)

Coverage includes:

• Risk stratification
• Medical management
• Novel therapeutic options
• Septal reduction strategies

Current Advances

• Disease-specific pharmacologic therapies
• Improved diagnostic approaches

🌬️ ECMO & Advanced Mechanical Support

Review of:

• Veno-arterial ECMO
• Cardiogenic shock support
• Bridge-to-transplant applications
• Bridge-to-recovery strategies

Clinical Decision Making

• Patient selection
• Timing of initiation
• Outcomes assessment

🫀 Structural Heart Disease & Valve Interventions

Role of structural interventions in heart failure patients:

• Transcatheter Aortic Valve Replacement (TAVR)
• Mitral Valve Repair
• Tricuspid Valve Interventions
• Percutaneous therapies

Clinical Applications

Improving symptoms and cardiac performance in advanced heart failure populations.

🏥 Advanced Heart Failure Team-Based Care

Importance of multidisciplinary collaboration among:

• Heart Failure Cardiologists
• Cardiac Surgeons
• Electrophysiologists
• Advanced Practice Providers
• Pharmacists
• Rehabilitation Specialists

Goal

Coordinated care that improves outcomes and reduces complications.

Who Should Attend

This course is ideal for:

Physicians

• Cardiologists
• Advanced Heart Failure Specialists
• Internists
• Hospitalists
• Cardiac Surgeons
• Electrophysiologists

Advanced Practice Providers

• Nurse Practitioners
• Physician Assistants

Trainees

• Cardiology Fellows
• Internal Medicine Residents

Allied Healthcare Professionals

• Heart Failure Nurses
• Clinical Pharmacists
• Cardiac Rehabilitation Professionals

Multidisciplinary Teams

• Heart Failure Programs
• Transplant Teams
• Mechanical Support Teams

Why This Course Is Valuable

✔ Advanced Heart Failure Updates

✔ Heart Transplantation Strategies

✔ LVAD & Mechanical Circulatory Support

✔ Cardiogenic Shock Management

✔ ECMO Applications

✔ Cardiac Amyloidosis Treatment

✔ Hypertrophic Cardiomyopathy Updates

✔ Cardiogenomics & Precision Medicine

✔ Structural Heart Interventions

✔ Hemodynamic Monitoring Techniques

✔ Multidisciplinary Care Models

✔ Evidence-Based Clinical Practice

Clinical & Educational Value

The AdventHealth Advanced Heart Failure CME 2025 program delivers a comprehensive review of modern heart failure care, focusing on advanced therapeutics, transplantation, mechanical circulatory support, cardiogenic shock management, and emerging precision medicine approaches. Through expert faculty guidance and practical case-based education, participants gain the knowledge necessary to identify high-risk patients earlier, optimize treatment strategies, and improve outcomes in advanced cardiovascular disease.

+ Topics:

• 01 When to Refer the Patient with Advanced Heart Failure for Consideration For HF & LVAD
• 02 Use of Cardiogenomics in Patients with Dilated Cardiomyopathy
• 03 Use of Echocardiography and Hemodynamics and Patients with Cardiogenic Shock
• 04 Cardiogenic Shock and Acute Myocardial Infarction
• 05 Outcomes in Elderly LVAD Patients
• 06 Frailty Assessment in the Evaluation for Advanced Heart Failure Surgical Therapies (LVAD and Transplant)
• 07 Updated Treatment Options for Patients with Amyloid & Hypertrophic Cardiomyopathy
• 08 Novel Percutaneous Devices in the Management of Cardiogenic Shock
• 09 Strategies to Increase Access to Heart Transplantation- Use of ECMO, Donation After Cardiac Death, and Hepatitis C Positive Donors